{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T21:35:59Z","timestamp":1747172159916,"version":"3.40.5"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Neurosurgery"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.wneu.2017.11.150","type":"journal-article","created":{"date-parts":[[2017,12,2]],"date-time":"2017-12-02T10:33:39Z","timestamp":1512210819000},"page":"397-402","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Long-Term Remission of Recurrent Brainstem Pilocytic Astrocytoma with Neuraxis Dissemination Using Recombinant Human Endostatin After Failure of Vincristine and Carboplatin"],"prefix":"10.1016","volume":"110","author":[{"given":"Jing-Jing","family":"Ge","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9827-0580","authenticated-orcid":false,"given":"Jun-Ping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.wneu.2017.11.150_bib1","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1002\/pbc.24958","article-title":"Long-term outcome of 4,040 children diagnosed with pediatric low-grade gliomas: an analysis of the Surveillance Epidemiology and End Results (SEER) database","volume":"61","author":"Bandopadhayay","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.wneu.2017.11.150_bib2","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0360-3016(97)00572-5","article-title":"Pediatric brain stem gliomas: a review","volume":"40","author":"Freeman","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.wneu.2017.11.150_bib3","doi-asserted-by":"crossref","first-page":"5277","DOI":"10.1200\/JCO.2006.07.2884","article-title":"Late-occurring stroke among long-term survivors of childhood leukemia and brain tumors: a report from the Childhood Cancer Survivor Study","volume":"24","author":"Bowers","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.wneu.2017.11.150_bib4","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/pbc.22557","article-title":"Vincristine and carboplatin chemotherapy for unresectable and\/or recurrent low-grade astrocytoma of the brainstem","volume":"55","author":"Ronghe","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.wneu.2017.11.150_bib5","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1200\/JCO.1993.11.5.850","article-title":"Carboplatin and vincristine for recurrent and newly diagnosed low-grade gliomas of childhood","volume":"11","author":"Packer","year":"1993","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.wneu.2017.11.150_bib6","first-page":"747","article-title":"Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas","volume":"86","author":"Packer","year":"1997","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2017.11.150_bib7","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1200\/JCO.2011.36.6054","article-title":"Randomized study of two chemotherapy regimens for treatment of low-grade glioma in young children: a report from the Children\u2019s Oncology Group","volume":"30","author":"Ater","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.wneu.2017.11.150_bib8","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1200\/JCO.2011.34.5843","article-title":"Phase II study of weekly vinblastine in recurrent or refractory pediatric low-grade glioma","volume":"30","author":"Bouffet","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.wneu.2017.11.150_bib9","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1200\/JCO.2016.68.1585","article-title":"Phase II weekly vinblastine for chemotherapy-naive children with progressive low-grade glioma: a Canadian Pediatric Brain Tumor Consortium Study","volume":"34","author":"Lassaletta","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"author":"Ludwig","key":"10.1016\/j.wneu.2017.11.150_bib10"},{"key":"10.1016\/j.wneu.2017.11.150_bib11","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1093\/neuonc\/nou059","article-title":"Phase II study of sorafenib in children with recurrent or progressive low-grade astrocytomas","volume":"16","author":"Karajannis","year":"2014","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.wneu.2017.11.150_bib12","first-page":"283","article-title":"[Results of randomized, multicenter, double-blind phase III trial of rh-endostatin (YH-16) in treatment of advanced non-small cell lung cancer patients.]","volume":"8","author":"Wang","year":"2005","journal-title":"Zhongguo Fei Ai Za Zhi"},{"key":"10.1016\/j.wneu.2017.11.150_bib13","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/1471-2407-13-248","article-title":"Neoadjuvant rh-endostatin, docetaxel and epirubicin for breast cancer: efficacy and safety in a prospective, randomized, phase II study","volume":"13","author":"Chen","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.wneu.2017.11.150_bib14","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1038\/mt.2013.79","article-title":"A\u00a0phase II, randomized, double-blind, placebo-controlled multicenter trial of Endostar in patients with metastatic melanoma","volume":"21","author":"Cui","year":"2013","journal-title":"Mol Ther"},{"key":"10.1016\/j.wneu.2017.11.150_bib15","first-page":"138","article-title":"[Randomized phase II trial on escalated doses of Rh-endostatin (YH-16) for advanced non-small cell lung cancer.]","volume":"28","author":"Yang","year":"2006","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"10.1016\/j.wneu.2017.11.150_bib16","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1200\/JCO.2012.44.1568","article-title":"Brainstem ganglioglioma successfully treated with vemurafenib","volume":"31","author":"Rush","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.wneu.2017.11.150_bib17","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/pbc.25787","article-title":"Successful retreatment of a child with a refractory brainstem ganglioglioma with vemurafenib","volume":"63","author":"Aguilera","year":"2016","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.wneu.2017.11.150_bib18","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.drup.2005.03.001","article-title":"Endostatin: the logic of antiangiogenic therapy","volume":"8","author":"Abdollahi","year":"2005","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.wneu.2017.11.150_bib19","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1083\/jcb.200203064","article-title":"Endostatin is a potential inhibitor of Wnt signaling","volume":"158","author":"Hanai","year":"2002","journal-title":"J\u00a0Cell Biol"},{"key":"10.1016\/j.wneu.2017.11.150_bib20","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.bbrc.2007.06.155","article-title":"Endostar, a novel recombinant human endostatin, exerts antiangiogenic effect via blocking VEGF-induced tyrosine phosphorylation of KDR\/Flk-1 of endothelial cells","volume":"361","author":"Ling","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.wneu.2017.11.150_bib21","doi-asserted-by":"crossref","first-page":"e107463","DOI":"10.1371\/journal.pone.0107463","article-title":"Endostar, a modified recombinant human endostatin, suppresses angiogenesis through inhibition of Wnt\/beta-catenin signaling pathway [e-pub ahead of print]","volume":"9","author":"Xu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.wneu.2017.11.150_bib22","doi-asserted-by":"crossref","first-page":"62619","DOI":"10.18632\/oncotarget.11547","article-title":"Combining antiangiogenic therapy with neoadjuvant chemotherapy increases treatment efficacy in stage IIIA (N2) non-small cell lung cancer without increasing adverse effects","volume":"7","author":"Zhao","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.wneu.2017.11.150_bib23","doi-asserted-by":"crossref","first-page":"373l","DOI":"10.1158\/0008-5472.CAN-04-0074","article-title":"Vascular normalization by vascular endothelial growth factor receptor 2 blockade induces a pressure gradient across the vasculature and improves drug penetration in tumors","volume":"64","author":"Tong","year":"2004","journal-title":"Cancer Res"}],"container-title":["World Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187887501732082X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187887501732082X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T16:05:39Z","timestamp":1603469139000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S187887501732082X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":23,"alternative-id":["S187887501732082X"],"URL":"https:\/\/doi.org\/10.1016\/j.wneu.2017.11.150","relation":{},"ISSN":["1878-8750"],"issn-type":[{"type":"print","value":"1878-8750"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-Term Remission of Recurrent Brainstem Pilocytic Astrocytoma with Neuraxis Dissemination Using Recombinant Human Endostatin After Failure of Vincristine and Carboplatin","name":"articletitle","label":"Article Title"},{"value":"World Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.wneu.2017.11.150","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}